CURIS, INC. Available-for-sale Securities
CURIS, INC. (CRIS) had Available-for-sale Securities of $48.44 million as of 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2013-11-12
- 2013-09-30: Available-for-sale Securities $48.44M.
- 2013-06-30: Available-for-sale Securities $47.39M.
- 2012-12-31: Available-for-sale Securities $42.79M.
| Period end | Available-for-sale Securities |
|---|---|
| 2013-09-30 | $48.44M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $47.39M 10-Q · filed 2013-08-08 |
| 2012-12-31 | $42.79M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |